Correction to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials
保存先:
主要な著者: | , , , , |
---|---|
フォーマット: | 図書 |
出版事項: |
BMC,
2021-08-01T00:00:00Z.
|
主題: | |
オンライン・アクセス: | Connect to this object online. |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_c5d3d97aa11d4fd8936da38c4e388be9 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Tatjana Welzel |e author |
700 | 1 | 0 | |a Carolyn Winskill |e author |
700 | 1 | 0 | |a Nancy Zhang |e author |
700 | 1 | 0 | |a Andreas Woerner |e author |
700 | 1 | 0 | |a Marc Pfister |e author |
245 | 0 | 0 | |a Correction to: Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trials |
260 | |b BMC, |c 2021-08-01T00:00:00Z. | ||
500 | |a 10.1186/s12969-021-00593-3 | ||
500 | |a 1546-0096 | ||
546 | |a EN | ||
690 | |a Pediatrics | ||
690 | |a RJ1-570 | ||
690 | |a Diseases of the musculoskeletal system | ||
690 | |a RC925-935 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Pediatric Rheumatology Online Journal, Vol 19, Iss 1, Pp 1-1 (2021) | |
787 | 0 | |n https://doi.org/10.1186/s12969-021-00593-3 | |
787 | 0 | |n https://doaj.org/toc/1546-0096 | |
856 | 4 | 1 | |u https://doaj.org/article/c5d3d97aa11d4fd8936da38c4e388be9 |z Connect to this object online. |